Dare Bioscience Inc.
DARE | NASDAQ
$0.84
+$0.03 (+3.70%)
Sep 22, 2026, 11:53 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 1.03M | 9.78K | 2.81M | 10M | n/a | n/a |
Cost of Revenue | 2.45M | 14.31M | 21.64M | 30.14M | 100K | 83.33K |
Gross Profit | -1.42M | -14.3M | -18.83M | -20.14M | -100K | -83.33K |
Operating Income | -13.55M | -23.45M | -30.94M | -31.39M | -39.07M | -27.4M |
Interest Income | 679.74K | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -13.4M | -4.05M | -30.16M | -30.95M | -38.7M | -27.4M |
Net Income | -13.4M | -4.05M | -30.16M | -30.95M | -38.7M | -27.4M |
Selling & General & Admin | 8.76M | 9.16M | 11.91M | 11.24M | 8.35M | 6.55M |
Research & Development | 5.52B | 14.21M | 21.54M | 30.04M | 30.62M | 20.77M |
Other Expenses | -5.52B | -14.21M | -21.34M | -30.04M | 1 | n/a |
Operating Expenses | 12.14M | 9.16M | 12.11M | 11.24M | 38.97M | 27.32M |
Interest Expense | 822.71K | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | 800K | 600K | 600K | 561K | 435K |
Cost & Expenses | 14.58M | 23.46M | 33.75M | 41.39M | 39.07M | 27.4M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 111.79M | 8.5M | 7.28M | 7.05M | 5.1M | 2.51M |
Shares Outstanding (Diluted) | 111.79M | 8.5M | 7.28M | 7.05M | 5.1M | 2.51M |
EPS (Basic) | -1.20 | -0.48 | -4.15 | -4.39 | -7.52 | -10.93 |
EPS (Diluted) | -1.20 | -0.48 | -4.15 | -4.39 | -7.52 | -10.93 |
EBITDA | -10.43M | -4.01M | -30.7M | -30.92M | -38.67M | -27.36M |
EBIT | -12.58M | -4.05M | -30.74M | -30.95M | -38.7M | -27.4M |
Depreciation & Amortization | 2.15M | 42.33K | 38.36K | 24.2K | 26.41K | 43.23K |
Add to Watchlist
Select watchlists to add or remove DARE